Clinical practice consensus for the diagnosis and management of melanoma in Taiwan

Chiao En Wu; Yi Hua Liao; Cheng Lin Wu; Ruoh Fang Yen; Chia Chi Lin; Muh Hwa Yang; Chueh Chuan Yen; Wu Chou Su; Chia Jui Yen; Yi Fang Chang; Ming Fang Wu; Youngsen Yang; Chen Yuan Lin; Wen Chi Yang; Hui Ching Wang; Cheng Yuan Li; Yin Yu Ho; Yao Yu Chang; Chieh Shan Wu; Hsiu Cheng Hsu; Kuang Hua Chen; Yenlin Huang; Chih Jung Chen; Pei Ju Chuang; Yung Chi Lai; Yu Yi Huang; Neng Chuan Tseng; Yi Ting Huang; Chia Yu Chu; John Wen-Cheng Chang

doi:10.1016/j.jfma.2023.07.016

Clinical practice consensus for the diagnosis and management of melanoma in Taiwan

Chiao En Wu, Yi Hua Liao, Cheng Lin Wu, Ruoh Fang Yen, Chia Chi Lin, Muh Hwa Yang, Chueh Chuan Yen, Wu Chou Su, Chia Jui Yen, Yi Fang Chang, Ming Fang Wu, Youngsen Yang, Chen Yuan Lin, Wen Chi Yang, Hui Ching Wang, Cheng Yuan Li, Yin Yu Ho, Yao Yu Chang, Chieh Shan Wu, Hsiu Cheng HsuKuang Hua Chen, Yenlin Huang, Chih Jung Chen, Pei Ju Chuang, Yung Chi Lai, Yu Yi Huang, Neng Chuan Tseng, Yi Ting Huang, Chia Yu Chu^*, John Wen-Cheng Chang^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

3 Scopus citations

Abstract

Melanoma is rare in Taiwan. Asian melanoma is distinct from Western melanoma because acral and mucosal melanoma accounts for the majority of melanoma cases, leading to distinct tumor behaviors and genetic profiling. With consideration of the clinical guidelines in Western countries, Taiwanese experts developed a local clinical practice consensus guideline. This consensus includes diagnosis, staging, and surgical and systemic treatment, based only on clinical evidence, local epidemiology, and available resources evaluated by experts in Taiwan. This consensus emphasizes the importance of surgical management, particularly for sentinel lymph node biopsies. In addition, molecular testing for BRAF is mandatory for patients before systemic treatment. Furthermore, immunotherapy and targeted therapy are prioritized for systemic treatment. This consensus aimed to assist clinicians in Taiwan in diagnosing and treating patients according to available evidence.

Original language	English
Pages (from-to)	7-15
Number of pages	9
Journal	Journal of the Formosan Medical Association
Volume	123
Issue number	1
DOIs	https://doi.org/10.1016/j.jfma.2023.07.016
State	Published - Jan 2024

Keywords

Acral melanoma
Immunotherapy
Melanoma
Mucosal melanoma
Targeted therapy

Access to Document

10.1016/j.jfma.2023.07.016

Cite this

Wu, C. E., Liao, Y. H., Wu, C. L., Yen, R. F., Lin, C. C., Yang, M. H., Yen, C. C., Su, W. C., Yen, C. J., Chang, Y. F., Wu, M. F., Yang, Y., Lin, C. Y., Yang, W. C., Wang, H. C., Li, C. Y., Ho, Y. Y., Chang, Y. Y., Wu, C. S., ... Wen-Cheng Chang, J. (2024). Clinical practice consensus for the diagnosis and management of melanoma in Taiwan. Journal of the Formosan Medical Association, 123(1), 7-15. https://doi.org/10.1016/j.jfma.2023.07.016

@article{ac80925ac74e4486be42d2c09b1013b6,

title = "Clinical practice consensus for the diagnosis and management of melanoma in Taiwan",

abstract = "Melanoma is rare in Taiwan. Asian melanoma is distinct from Western melanoma because acral and mucosal melanoma accounts for the majority of melanoma cases, leading to distinct tumor behaviors and genetic profiling. With consideration of the clinical guidelines in Western countries, Taiwanese experts developed a local clinical practice consensus guideline. This consensus includes diagnosis, staging, and surgical and systemic treatment, based only on clinical evidence, local epidemiology, and available resources evaluated by experts in Taiwan. This consensus emphasizes the importance of surgical management, particularly for sentinel lymph node biopsies. In addition, molecular testing for BRAF is mandatory for patients before systemic treatment. Furthermore, immunotherapy and targeted therapy are prioritized for systemic treatment. This consensus aimed to assist clinicians in Taiwan in diagnosing and treating patients according to available evidence.",

keywords = "Acral melanoma, Immunotherapy, Melanoma, Mucosal melanoma, Targeted therapy",

author = "Wu, {Chiao En} and Liao, {Yi Hua} and Wu, {Cheng Lin} and Yen, {Ruoh Fang} and Lin, {Chia Chi} and Yang, {Muh Hwa} and Yen, {Chueh Chuan} and Su, {Wu Chou} and Yen, {Chia Jui} and Chang, {Yi Fang} and Wu, {Ming Fang} and Youngsen Yang and Lin, {Chen Yuan} and Yang, {Wen Chi} and Wang, {Hui Ching} and Li, {Cheng Yuan} and Ho, {Yin Yu} and Chang, {Yao Yu} and Wu, {Chieh Shan} and Hsu, {Hsiu Cheng} and Chen, {Kuang Hua} and Yenlin Huang and Chen, {Chih Jung} and Chuang, {Pei Ju} and Lai, {Yung Chi} and Huang, {Yu Yi} and Tseng, {Neng Chuan} and Huang, {Yi Ting} and Chu, {Chia Yu} and {Wen-Cheng Chang}, John",

note = "Publisher Copyright: {\textcopyright} 2023",

year = "2024",

month = jan,

doi = "10.1016/j.jfma.2023.07.016",

language = "English",

volume = "123",

pages = "7--15",

journal = "Journal of the Formosan Medical Association",

issn = "0929-6646",

publisher = "Elsevier B.V.",

number = "1",

}

Wu, CE, Liao, YH, Wu, CL, Yen, RF, Lin, CC, Yang, MH, Yen, CC, Su, WC, Yen, CJ, Chang, YF, Wu, MF, Yang, Y, Lin, CY, Yang, WC, Wang, HC, Li, CY, Ho, YY, Chang, YY, Wu, CS, Hsu, HC, Chen, KH, Huang, Y, Chen, CJ, Chuang, PJ, Lai, YC, Huang, YY, Tseng, NC, Huang, YT, Chu, CY & Wen-Cheng Chang, J 2024, 'Clinical practice consensus for the diagnosis and management of melanoma in Taiwan', Journal of the Formosan Medical Association, vol. 123, no. 1, pp. 7-15. https://doi.org/10.1016/j.jfma.2023.07.016

TY - JOUR

T1 - Clinical practice consensus for the diagnosis and management of melanoma in Taiwan

AU - Wu, Chiao En

AU - Liao, Yi Hua

AU - Wu, Cheng Lin

AU - Yen, Ruoh Fang

AU - Lin, Chia Chi

AU - Yang, Muh Hwa

AU - Yen, Chueh Chuan

AU - Su, Wu Chou

AU - Yen, Chia Jui

AU - Chang, Yi Fang

AU - Wu, Ming Fang

AU - Yang, Youngsen

AU - Lin, Chen Yuan

AU - Yang, Wen Chi

AU - Wang, Hui Ching

AU - Li, Cheng Yuan

AU - Ho, Yin Yu

AU - Chang, Yao Yu

AU - Wu, Chieh Shan

AU - Hsu, Hsiu Cheng

AU - Chen, Kuang Hua

AU - Huang, Yenlin

AU - Chen, Chih Jung

AU - Chuang, Pei Ju

AU - Lai, Yung Chi

AU - Huang, Yu Yi

AU - Tseng, Neng Chuan

AU - Huang, Yi Ting

AU - Chu, Chia Yu

AU - Wen-Cheng Chang, John

PY - 2024/1

Y1 - 2024/1

N2 - Melanoma is rare in Taiwan. Asian melanoma is distinct from Western melanoma because acral and mucosal melanoma accounts for the majority of melanoma cases, leading to distinct tumor behaviors and genetic profiling. With consideration of the clinical guidelines in Western countries, Taiwanese experts developed a local clinical practice consensus guideline. This consensus includes diagnosis, staging, and surgical and systemic treatment, based only on clinical evidence, local epidemiology, and available resources evaluated by experts in Taiwan. This consensus emphasizes the importance of surgical management, particularly for sentinel lymph node biopsies. In addition, molecular testing for BRAF is mandatory for patients before systemic treatment. Furthermore, immunotherapy and targeted therapy are prioritized for systemic treatment. This consensus aimed to assist clinicians in Taiwan in diagnosing and treating patients according to available evidence.

AB - Melanoma is rare in Taiwan. Asian melanoma is distinct from Western melanoma because acral and mucosal melanoma accounts for the majority of melanoma cases, leading to distinct tumor behaviors and genetic profiling. With consideration of the clinical guidelines in Western countries, Taiwanese experts developed a local clinical practice consensus guideline. This consensus includes diagnosis, staging, and surgical and systemic treatment, based only on clinical evidence, local epidemiology, and available resources evaluated by experts in Taiwan. This consensus emphasizes the importance of surgical management, particularly for sentinel lymph node biopsies. In addition, molecular testing for BRAF is mandatory for patients before systemic treatment. Furthermore, immunotherapy and targeted therapy are prioritized for systemic treatment. This consensus aimed to assist clinicians in Taiwan in diagnosing and treating patients according to available evidence.

KW - Acral melanoma

KW - Immunotherapy

KW - Melanoma

KW - Mucosal melanoma

KW - Targeted therapy

UR - http://www.scopus.com/inward/record.url?scp=85170226505&partnerID=8YFLogxK

U2 - 10.1016/j.jfma.2023.07.016

DO - 10.1016/j.jfma.2023.07.016

M3 - Article

C2 - 37690868

AN - SCOPUS:85170226505

SN - 0929-6646

VL - 123

SP - 7

EP - 15

JO - Journal of the Formosan Medical Association

JF - Journal of the Formosan Medical Association

IS - 1

ER -

Clinical practice consensus for the diagnosis and management of melanoma in Taiwan

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this